Name: TRADR 2X LONG SNPS DAILY ETF (SNPX) Stock
Brand: TRADR 2X LONG SNPS DAILY ETF
Rating: 6.5 (3 reviews)

Question 1

What does TRADR 2X LONG SNPS DAILY ETF do?

Accepted Answer

Synaptogenix, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the development of Bryostatin and Platform Drug used for the treatment of Alzheimer’s disease, Fragile X Syndrome or Autism, Multiple Sclerosis, Parkinson’s Disease, Traumatic Brain Injury, and Stroke. The company is headquartered in New York City, New York and currently employs 4 full-time employees. The company went IPO on 2020-12-07. The firm is principally focused on developing a product platform based upon a drug candidate called Bryostatin-1, which is synthesized from a natural product (bryostatin) that is isolated from a marine invertebrate organism, for the treatment of Alzheimer’s disease (AD), which is in the clinical testing stage. Preclinical studies have also demonstrated bryostatin's regenerative mechanisms of action for the rare disease Fragile X syndrome, and for other neurodegenerative disorders such as multiple sclerosis, stroke, and traumatic brain injury. The firm is also evaluating potential therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis (MS), and Niemann-Pick Type C disease, which have undergone pre-clinical testing.

Question 2

What is the stock price of TRADR 2X LONG SNPS DAILY ETF today?

Accepted Answer

The current stock price of SNPX is 35.26 USD. The price increased by 4.04% in the last trading session.

Question 3

What is the ChartMill technical and fundamental rating of SNPX stock?

Accepted Answer

SNPX has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 2 out of 10.

Show Percentage Diff	TTM (2025-3-31)	2024 (2024-12-31)	2023 (2023-12-31)	2022 (2022-12-31)	2021 (2021-12-31)
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income	-12.18M	-12.77M	-6.04M	-5.57M	-12.61M
Depreciation Amortization	5.20K	5.60K	6.40K	5.70K	5.00K
Change In Working Capital	2.60K	501.90K	358.00K	-615.00K	25.90K
Other non cash items	7.12M	7.38M	500.90K	-5.03M	3.87M
OPERATING CASH FLOW	-5.05M	-4.88M	-5.17M	-11.21M	-8.71M

CASH FLOWS FROM INVESTING ACTIVITIES
Capital Expenditure	N/A	N/A	-2.70K	-7.40K	-3.20K
Other Investing Activity	-500.00K	-1.00M	-2.00M	N/A	N/A
INVESTING CASH FLOW	-500.00K	-1.00M	-2.00M	-7.40K	-3.20K

CASH FLOWS FROM FINANCING ACTIVITIES
Stock Issued/Repurchased	N/A	-4.17M	-1.00M	14.48M	37.13M
Dividend Paid	N/A	-950.90K	-641.10K	N/A	N/A
Other Financing Activity	N/A	N/A	N/A	0.00	-1.50K
FINANCING CASH FLOW	N/A	-5.12M	-1.64M	14.48M	37.13M

CHANGE IN CASH	-11.50M	-11.01M	-8.82M	3.26M	28.42M

FREE CASH FLOW
Operating Cash Flow	-5.05M	-4.88M	-5.17M	-11.21M	-8.71M
Capital Expenditure	N/A	N/A	-2.70K	-7.40K	-3.20K
FREE CASH FLOW	-5.05M	-4.88M	-5.18M	-11.22M	-8.71M

TRADR 2X LONG SNPS DAILY ETF (SNPX) Stock Price, Forecast & Analysis

Charts